Efficacy and Safety Analysis of Transarterial Chemoembolization Plus Donafenib With or Without Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Prospective, Single-Arm, Single-Center, Phase II Clinical Study

Jinpeng Li,1,2 Yan Li,3 Jinlong Song,2 Lujun Zhao1 1Department of Radiation Oncology,Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Li J, Li Y, Song J, Zhao L
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Dove Medical Press 2024-06-01
Serie:	Journal of Hepatocellular Carcinoma
Soggetti:	hepatocellular carcinoma donafenib transarterial chemoembolization immune checkpoint inhibitors safety efficacy
Accesso online:	https://www.dovepress.com/efficacy-and-safety-analysis-of-transarterial-chemoembolization-plus-d-peer-reviewed-fulltext-article-JHC
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!